天美传媒

Jump to Main Content

About ASH

Committee聽on Diversity, Equity, and Inclusion

Committee Roster

Chair
Alison 聽R.聽Walker,聽MD, MBA, MPH 聽('24)

Vice Chair
Alex 聽Francisco聽Herrera,聽MD 聽('24)

Appointed Members
Allistair聽Abraham,聽MD 聽('24)
Staci 聽D.聽Arnold,聽MD, MBA, MPH 聽('25)
Brandon聽Blue,聽MD 聽('25)
Gregory 聽Sampang聽Calip,聽PhD, PharmD, MPH 聽('26)
Blachy 聽J.聽Davila Saldana,聽MD 聽('25)
Marcos聽de Lima,聽MD 聽('25)
Srinivas 聽S.聽Devarakonda,聽MD 聽('26)
Warren聽Fingrut,聽MD 聽('26)
Beatrice聽Gee,聽MD 聽('27)
Kalpna聽Gupta,聽PhD 聽('25)
Monique聽Hartley-Brown,聽MD 聽('25)
E. Leila 聽Jerome聽Jerome Clay,聽MD 聽('24)
Frederick聽Lansigan,聽MD 聽('26)
Rakesh聽Mehta,聽MD 聽('27)
Jonathan聽Moreira,聽MD 聽('25)
Oreofe 聽O.聽Odejide,聽MD, MPH 聽('27)
Kerice 聽A.聽Pinkney,聽MD 聽('27)
Rayne 聽H.聽Rouce,聽MD 聽('26)
Melody聽Smith,聽MD, MS 聽('26)
Noha聽Soror,聽MD, MSc 聽('24)
Georgia 聽B.聽Vogelsang,聽MD 聽('25)
Rahma聽Warsame,聽MD 聽('24)
David 聽S.聽Wilkes,聽MD 聽('27)

Ex Officio Members
Belinda聽Avalos,聽MD 聽('25) 聽-聽President-Elect
Mohandas聽Narla,聽DSc 聽('24) 聽-聽President
Robert聽Negrin,聽MD 聽('26) 聽-聽Vice President

Liaisons
Glaivy聽Batsuli,聽MD 聽-聽Co-Chair, Women in Hematology Working Group
Lisa 聽Kristine聽Hicks,聽MD, MSc 聽('26) 聽-聽Health Equity Task Force Co-Chair
Abner聽Louissaint,聽MD, PhD 聽('25) 聽-聽Publications Committee
Kellie聽Machlus,聽PhD 聽('25) 聽-聽Nominating Committee
Ruben 聽A.聽Mesa,聽MD 聽('26) 聽-聽Health Equity Task Force Co-Chair
Arturo聽Molina,聽MD, MS 聽-聽ASH Representative to AMFDP NAC
Margo 聽Renee聽Rollins,聽MD 聽('27) 聽-聽Chair, MRI Programs Subcommittee
Bethany聽Samuelson Bannow,聽MD 聽-聽Co-Chair, Women in Hematology Working Group

Staff Liaison
笔补迟谤颈肠颈补听贵谤耻蝉迟补肠别

Committee Mandate

The Committee on Diversity, Equity, and Inclusion (DEI) is responsible for leading efforts to achieve the commitments delineated in the ASH DEI statement.

 

The work of the Committee on DEI includes:

 

           Establishing the vision and strategy for achieving ASH鈥檚 DEI priorities.

           Strengthening ASH鈥檚 awareness and understanding of the issues that drive the need for DEI work and ensuring that ASH remains on the forefront of this work.

           Understanding and disseminating DEI best practices throughout ASH committees and programs.

           Identifying opportunities for accelerating DEI within the field.

           Advising peer committees on gaps and opportunities for achieving DEI priorities.

           Advocating for ASH DEI efforts and priorities within peer networks to increase awareness and engagement in this work.

           Measuring the impact of on-going DEI efforts.

 

The Committee on DEI structure includes at least two ASH members who have a PhD designation (to ensure that the interests of this constituency are represented) as well as the following liaison members:

 

           Nominating Committee member (term congruent to service on parent committee)

           Publications Committee member (term congruent to service on parent committee)

           ASH representative to Amos Medical Faculty Development Program National Advisory Committee

           Chair of MRI Programs Subcommittee (under purview of Committee on DEI)

           Co-Chairs of Health Equity Task Force (under auspices of Committee on DEI)

           Co-chairs of Women in Hematology Working Group

 

Members of the Committee on DEI are required to attend two meetings per year: one in the spring and one in the fall. They are further expected to directly engage in individual and small group projects at the direction of the chair. Finally, they are expected but not required, to participate in at least one MRI study section during their term.

 

The chair of the Committee on DEI serves as a liaison member of the Program Committee and the Media Experts Subcommittee and is expected to attend the meetings of those committees. Members of the committee serves as liaison members of the Awards Committee; Committee on Government Affairs; Committee on Practice; Committee on Quality; Committee on Scientific Affairs; Committee on Training; ASH Ambassador Oversight Subcommittee; and Task Force on PhD Careers in Hematology and are expected to attend the meetings of those committees.

 

The Committee on DEI makes funding recommendations to the ASH Executive Committee which serves as the ultimate arbiter for funding approvals.

...